ITR-251 at RP2D: Clinical Trials

1 trial of ITR-251 at RP2D, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Not yet recruiting 1

Follow ITR-251 at RP2D: new trials by email Literature Review of ITR-251 at RP2D trials Research Report on ITR-251 at RP2D

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ITR-251 in Patients With Advanced Solid Tumors
ITR-251, ITR-251 at RP2D, ARPI therapy - Solid Tumor Cancer, Castration Resistant Metastatic Prostate Cancer
Phase 1Not yet recruitingITERIA BIOPHARMA, S.L.462026-10-012026-10-13

Sponsors

ITERIA BIOPHARMA, S.L. (1)

Countries

Spain (1)

Top investigators

Josep M Piulats, M.D.; Ph.D. (1)